GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sun Pharmaceutical Industries Ltd

Sun Pharma Board Appoints Deloitte Haskins & Sells as Statutory Auditors

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 30 Oct 2026, 03:17 PM IST  ·  BSE ID: ec707522-529d-49a5-bc71-3e7f7df28129
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors have chosen a new external accountant firm to check its books for the next five years.
🤖 AI Summary
  • Sun Pharma Board approves appointment of Deloitte Haskins & Sells as new Statutory Auditors.
  • New auditors to serve for five consecutive years, commencing FY27 AGM.
  • Current auditors, SRBC & CO LLP, complete tenure due to mandatory rotation.
  • Appointment subject to shareholder approval at the upcoming Annual General Meeting.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will engage a new firm for its statutory audit process, requiring transition and integration of audit procedures.
⚠️
Risk Impact
Changes in auditors can introduce new perspectives on financial reporting and compliance, impacting the perceived reliability of financial statements.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to vote on the appointment of Deloitte Haskins & Sells as Statutory Auditors.
👤
Who Is Affected
All shareholders of Sun Pharmaceutical Industries Ltd will have their voting rights exercised on the auditor appointment.
🔍
Management Signal
The board is adhering to regulatory requirements for auditor rotation, demonstrating commitment to corporate governance standards.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM notice for shareholder vote on auditor appointment.
Shareholder meeting outcome regarding auditor approval.
Commencement of Deloitte's audit for FY27 financial statements.
LOW RISK Auditor appointment is a routine governance requirement under Companies Act, 2013.
💡 Investor Takeaway
Sun Pharma's Board has approved Deloitte Haskins & Sells as new statutory auditors for five years, pending shareholder vote, due to mandatory rotation.
❓ Frequently Asked Questions
Who has Sun Pharma's Board approved as new Statutory Auditors?
The Board has approved the appointment of Deloitte Haskins & Sells Chartered Accountants LLP as the new Statutory Auditors.
For how long will Deloitte Haskins & Sells serve as Sun Pharma's Statutory Auditors?
They will serve for a term of five consecutive years, commencing from the conclusion of the AGM for the financial year 2026-27.
Why is Sun Pharma appointing new Statutory Auditors?
Sun Pharma is appointing new auditors due to mandatory auditor rotation requirements under Section 139(2) of the Companies Act, 2013.
Is the appointment of Deloitte Haskins & Sells final?
The appointment is subject to the approval of the shareholders of the Company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.